OPKO Health (OPK) stockholders approve directors, equity plan and auditor
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
OPKO Health, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 18, 2026. Stockholders elected eleven directors, each receiving more votes "For" than "Against", including Phillip Frost, M.D. with 423,666,978 votes for and 40,175,942 against.
Stockholders approved the Company’s 2026 Equity Incentive Plan, with 440,096,997 votes for and 23,694,041 against. They also approved, on a non-binding advisory basis, the compensation of the named executive officers, with 446,238,170 votes for and 17,487,326 against.
In addition, stockholders ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 535,070,921 votes for and 6,120,699 against. No other matters were considered or voted upon at the meeting.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Director votes – Phillip Frost: 423,666,978 For; 40,175,942 Against
Equity Incentive Plan approval: 440,096,997 For; 23,694,041 Against
Say-on-pay advisory vote: 446,238,170 For; 17,487,326 Against
+3 more
6 metrics
Director votes – Phillip Frost
423,666,978 For; 40,175,942 Against
Election of directors at 2026 Annual Meeting
Equity Incentive Plan approval
440,096,997 For; 23,694,041 Against
2026 Equity Incentive Plan stockholder vote
Say-on-pay advisory vote
446,238,170 For; 17,487,326 Against
Non-binding vote on executive compensation
Auditor ratification
535,070,921 For; 6,120,699 Against
Ernst & Young LLP ratified for FY ending Dec. 31, 2026
Equity Plan broker non-votes
79,767,645
Broker non-votes on 2026 Equity Incentive Plan proposal
Say-on-pay broker non-votes
79,767,645
Broker non-votes on advisory compensation proposal
Key Terms
broker non-votes, 2026 Equity Incentive Plan, non-binding advisory basis, independent registered public accounting firm, +1 more
5 terms
broker non-votes financial
"Each director election line item lists For, Against, Abstain, and Broker Non-Votes."
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
2026 Equity Incentive Plan financial
"The stockholders voted to approve the Company’s 2026 Equity Incentive Plan as disclosed in the Company’s 2026 Proxy Statement."
non-binding advisory basis regulatory
"The stockholders voted to approve, on a non-binding advisory basis, the compensation of the named executive officers."
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
independent registered public accounting firm regulatory
"The stockholders voted to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm."
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Annual Meeting of Stockholders financial
"OPKO Health, Inc. held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”)."
FAQ
What did OPKO Health (OPK) stockholders decide at the 2026 annual meeting?
Stockholders elected eleven directors and approved all major proposals. They backed the 2026 Equity Incentive Plan, supported executive compensation on an advisory basis, and ratified Ernst & Young LLP as auditor for the 2026 fiscal year.
Did OPKO Health (OPK) stockholders approve the 2026 Equity Incentive Plan?
Yes, stockholders approved the 2026 Equity Incentive Plan with 440,096,997 votes for and 23,694,041 against. This plan was described in the company’s 2026 proxy statement for the annual meeting and governs future equity-based compensation.
How did OPKO Health (OPK) stockholders vote on executive compensation?
On a non-binding advisory basis, stockholders approved named executive officer compensation with 446,238,170 votes for and 17,487,326 against. This say-on-pay vote reflects current shareholder support for the disclosed compensation program and practices.
Who is OPKO Health’s (OPK) independent auditor for fiscal year 2026?
Stockholders ratified Ernst & Young LLP as OPKO Health’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 535,070,921 votes for and 6,120,699 against, and 2,715,188 abstentions recorded.
Were all OPKO Health (OPK) director nominees elected at the 2026 meeting?
All eleven director nominees were elected, each receiving more votes for than against. For example, Phillip Frost, M.D. received 423,666,978 votes for and 40,175,942 against, with additional broker non-votes reported on the director election items.
Were there any other matters voted on at OPKO Health’s 2026 annual meeting?
No, only four proposals were considered: election of directors, approval of the 2026 Equity Incentive Plan, advisory approval of executive compensation, and auditor ratification. The company reported that no other matters were submitted for stockholder vote.